Cowen and Company’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-25,000
Closed -$19K 739
2021
Q4
$19K Hold
25,000
﹤0.01% 539
2021
Q3
$25K Buy
+25,000
New +$355K ﹤0.01% 467
2021
Q2
Sell
-6,100
Closed -$7K 708
2021
Q1
$7K Buy
+6,100
New +$99.4K ﹤0.01% 504

Other funds holding VTRS

Cowen and Company's VTRS Position: Q1 2022 in Review

Cowen and Company sold out of Viatris (VTRS) in Q1 2022, closing a stake of 6,939 shares — an estimated $94K sold.

Cowen and Company first reported a position in VTRS in Q1 2021 and held it in 3 quarters. The position peaked at $94K in Q4 2021. 1,023 funds tracked by Wall St. Rank hold VTRS as of Q1 2022.

  • Cowen and Company reported no remaining Viatris position as of Q1 2022 after selling out during the quarter.
  • Cowen and Company sold 6,939 Viatris shares in Q1 2022, an estimated $94K.
  • Cowen and Company first reported a position in Viatris in Q1 2021 and held it in 3 quarters.
  • Cowen and Company's Viatris position peaked at $94K in Q4 2021.
  • 1,023 funds tracked by Wall St. Rank held Viatris as of Q1 2022.

Based on Cowen and Company's 13F filing for Q1 2022, filed 16 May 2022.